1.Proliferation of Toxoplasma gondii Suppresses Host Cell Autophagy.
Youn Jin LEE ; Hyun Ouk SONG ; Young Ha LEE ; Jae Sook RYU ; Myoung Hee AHN
The Korean Journal of Parasitology 2013;51(3):279-287
Autophagy is a process of cytoplasmic degradation of endogenous proteins and organelles. Although its primary role is protective, it can also contribute to cell death. Recently, autophagy was found to play a role in the activation of host defense against intracellular pathogens. The aims of our study was to investigate whether host cell autophagy influences Toxoplasma gondii proliferation and whether autophagy inhibitors modulate cell survival. HeLa cells were infected with T. gondii with and without rapamycin treatment to induce autophagy. Lactate dehydrogenase assays showed that cell death was extensive at 36-48 hr after infection in cells treated with T. gondii with or without rapamycin. The autophagic markers, LC3 II and Beclin 1, were strongly expressed at 18-24 hr after exposure as shown by Western blotting and RT-PCR. However, the subsequent T. gondii proliferation suppressed autophagy at 36 hr post-infection. Pre-treatment with the autophagy inhibitor, 3-methyladenine (3-MA), down-regulated LC3 II and Beclin 1. The latter was also down-regulated by calpeptin, a calpain inhibitor. Monodansyl cadaverine (MDC) staining detected numerous autophagic vacuoles (AVs) at 18 hr post-infection. Ultrastructural observations showed T. gondii proliferation in parasitophorous vacuoles (PVs) coinciding with a decline in the numbers of AVs by 18 hr. FACS analysis failed to confirm the presence of cell apoptosis after exposure to T. gondii and rapamycin. We concluded that T. gondii proliferation may inhibit host cell autophagy and has an impact on cell survival.
Anti-Bacterial Agents/pharmacology
;
Apoptosis/drug effects/physiology
;
Autophagy/drug effects
;
HeLa Cells
;
Humans
;
Sirolimus/pharmacology
;
Toxoplasma/*cytology/*physiology
2.Short interfering RNA-mediated inhibition of coxsakievirus B3 infection in vitro.
Ji-sheng HAN ; Zong-hui XIAO ; Hai-lan YAO ; Hong-yan REN ; Zhe-wei LIU
Chinese Journal of Experimental and Clinical Virology 2007;21(2):150-152
OBJECTIVETo evaluate feasibility of inhibiting coxsackievirus B3 (CVB3) infection at cellular, protein and gene levels by using small interfering RNA (siRNA).
METHODSAntiviral activities of siRNAs were evaluated by observing cytopathic effect (CPE), using plaque reduction Western blotting assays and RT-PCR.
RESULTSEight siRNAs were synthesized, among them, SiRNA-2, SiRNA-3, SiRNA-6 and SiRNA-7 which were targeted against sequences located in 2B, VP4, 2A and 3C section of CVB3 genome, were designed to have different effect of inhibiting CVB3 infection in vitro. SiRNA-2 showed the best protective effect, 95 percent inhibition of CVB3 cytopathic effect and plaque forming effect was observed at 0.0001 MOI, viral protein synthesis and replication were inhibited. SiRNA-2 showed 30 percent inhibition of virus at 0.1 MOI, 70 percent inhibition at 0.01 MOI, 88 percent inhibition at 0.001 MOI, and 99 percent inhibition at 0.0001 MOI 48 hours after CVB3 infection.
CONCLUSIONSiRNA could effectively inhibit CVB3 infection in vitro, siRNA-2, which is targeted against sequence in 2B section of CVB3 genome, seemed to be the best one among those synthesized in this study.
Coxsackievirus Infections ; therapy ; virology ; Cytopathogenic Effect, Viral ; drug effects ; Enterovirus ; genetics ; physiology ; HeLa Cells ; Humans ; RNA Interference ; RNA, Small Interfering ; genetics ; therapeutic use ; Virus Replication ; drug effects
3.Effect and mechanism of Saururus chinensis against herpes dimplex virus.
Lei TIAN ; Xiaoyan LI ; Yunxia XU ; Erguang LI
China Journal of Chinese Materia Medica 2012;37(11):1642-1645
OBJECTIVETo seek effective drugs inhibiting herpes simplex virus (HSV-2) with the signal pathway required by virus replication as the target spot.
METHODHSV-2-induced Vero cytopathic effect was observed, and MTT method was adopted to detect call activity, in order to assess the antiviral capacity of freeze dried powder of aqueous extracts of Saururus chinensis (AESC). Western blot was used to check the effect of AESC on signal pathway induced by HSV-2 virus in HeLa cells.
RESULTAESC obviously inhibits the pathway activation of CPE induced by HSV-2 infection and NF-kappaB required for virus replication. The inhibition ratio of AESC freeze dried powder at 0.10, 0.03, 0.01 and 0.003 g x L(-1) were (70.68 +/- 3.39)%, (61.74 +/- 2.13)%, (39.31 +/- 1.10)% and (18.54 +/- 3.44)%, respectively. The IC50 was determined at (0.023 +/- 0.004) g x L(-1). The inhibition concentration of the positive control acyclovir was 0.001 g x L(-1) (5.0 x 10(-6) mol x L(-1)). The best administration time was from 2 h before infection to 6 h after infection. Western blot also showed that AESC can notably inhibit HSV-2-induced NF-kappaB nuclear transfer.
CONCLUSIONAESC can inhibit HSV-2 virus replication, which is related to the pathway activation of NF-kappaB required for virus replication.
Animals ; Antiviral Agents ; pharmacology ; toxicity ; Cercopithecus aethiops ; Drugs, Chinese Herbal ; pharmacology ; toxicity ; HeLa Cells ; Herpesvirus 2, Human ; drug effects ; physiology ; Humans ; NF-kappa B ; metabolism ; Saururaceae ; chemistry ; Signal Transduction ; drug effects ; Vero Cells ; Virus Replication ; drug effects
4.The effect of co-immobilized TNF-alpha/IFN-gamma on mitochondrial membrane potential of HeLa cells.
Lianmin ZHONG ; Wenwen WANG ; Huimin TAO ; Yanqing GUAN
Journal of Biomedical Engineering 2009;26(5):972-977
This study inquired into the mechanisms of co-immobilized cytokines and free cytokines-induced apoptosis on HeLa cells. With the use of photochemical fixed method, TNF-alpha/IFN-gamma were co-immobilized on a 24-well polystyrene culture plate. HeLa cells were stained with fluorescent probe JC-1 to detect the changes of mitochondrial membrane potential (deltapsim), and then were examined by flow cytometry. The results showed that co-immobilized cytokines could induce the apoptosis of HeLa cells in a dose-independent manner. When treated with low-dose of co-immobilized cytokines (20ng/ml), the mitochondrial membrane potential (deltapsim) of HeLa cells continually decreased in 6 days. These indicate that low dose co-immobilized cytokines have a long-term of apoptosis-inducing effect on HeLa cells. We assume that there is close relationship between the mitochondrial membrane potential decrease and the apoptosis of HeLa cells.
Apoptosis
;
drug effects
;
Dose-Response Relationship, Drug
;
HeLa Cells
;
Humans
;
Immobilized Proteins
;
pharmacology
;
Interferon-gamma
;
pharmacology
;
Membrane Potential, Mitochondrial
;
drug effects
;
Mitochondrial Membranes
;
drug effects
;
physiology
;
Tumor Necrosis Factor-alpha
;
pharmacology
5.Involvement of JNK-initiated p53 accumulation and phosphorylation of p53 in pseudolaric acid B induced cell death.
Xianfeng GONG ; Minwei WANG ; Shin ichi TASHIRO ; Satoshi ONODERA ; Takashi IKEJIMA
Experimental & Molecular Medicine 2006;38(4):428-434
A terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay was used to determine that apoptosis causes HeLa cell death induced by pseudolaric acid B. The c-Jun N-terminal kinase (JNK) inhibitor SP600125 decreased p53 protein expression during exposure to pseudolaric acid B. SP600125 decreased the phosphorylation of p53 during pseudolaric acid B exposure, indicating that JNK mediates phosphorylation of p53 during the response to pseudolaric acid B. SP600125 reversed pseudolaric acid B-induced down-regulation of phosphorylated extracellular signal-regulated protein kinase (ERK), and protein kinase C (PKC) was activated by pseudolaric acid B, whereas staurosporine, calphostin C, and H7 partly blocked this effect. These results indicate that p53 is partially regulated by JNK in pseudolaric acid B-induced HeLa cell death and that PKC participates in pseudolaric acid B-induced HeLa cell death.
Tumor Suppressor Protein p53/metabolism/*physiology
;
Protein Kinase C/metabolism
;
Phosphorylation
;
JNK Mitogen-Activated Protein Kinases/*physiology
;
Humans
;
Hela Cells
;
Diterpenes/*pharmacology
;
DNA Fragmentation/drug effects
;
Cell Death/*drug effects
;
Anthracenes/pharmacology
6.Telomerase activity,PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line.
Xiao-Xia YU ; Ying-Ai SHI ; Li-Hong ZHANG ; Yi-Shu WANG ; Shan WU
Chinese Journal of Pathology 2008;37(5):323-327
OBJECTIVETo investigate the telomerase activity and to document biological behaviors of HeLa cells upon treatment with specific PI3K/AKT signaling pathway inhibitor, LY294002.
METHODSCCK-8 assay was used to determine IC50 of LY294002. The expressions of total AKT and phosphorylation AKT (P-AKT) were determined using Western blot. Telomerase activity of cell was measured by TRAP-ELISA assay. Cell growth curve, flow cytometry technique and Hoechst33258 stain were used to evaluate the cell growth, cell cycle and apoptosis respectively. Cell migration was determined by cell wound healing assay.
RESULTSIC50 value of LY294002 of treated HeLa cells was 1.73 mg/L. Western blot showed that LY294002 enabled to decrease P-AKT activity in the presence of same total AKT protein. The cell telomerase activity was decreased to 36.72% in contrast to 98.61% of the control. LY294002 decreased the telomerase activity in HeLa cells, and the growth capacity of the cells was significantly suppressed. The number of cells at G0/G1 phases increased to 66.88% compared with that of the control cells (47.36%). The apoptosis rate also increased from 2.4% to 14.9%. The relative migration distance decreased to 24.6% compared with that of control (62.57%).
CONCLUSIONLY294002 inhibition of PI3K/AKT signaling pathway leads to alteration of telomerase activity along with changes of the biological behaviors of the HeLa cells suggesting that regulation of telomerase activity may be closely related to PI3K/AKT signaling pathway.
Apoptosis ; drug effects ; Blotting, Western ; Cell Line ; Cell Movement ; drug effects ; physiology ; Cell Proliferation ; drug effects ; Chromones ; pharmacology ; Enzyme Inhibitors ; pharmacology ; G1 Phase ; drug effects ; HeLa Cells ; Humans ; Morpholines ; pharmacology ; Phosphatidylinositol 3-Kinases ; antagonists & inhibitors ; Phosphorylation ; drug effects ; Proto-Oncogene Proteins c-akt ; Signal Transduction ; drug effects ; physiology ; Telomerase
7.Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2.
Boe Eun KIM ; Jeong Hwa LEE ; Ho Shik KIM ; Oh Joo KWON ; Seong Whan JEONG ; In Kyung KIM
Experimental & Molecular Medicine 2004;36(5):444-453
delta12-Prostaglandin (PG) J2 is known to elicit an anti-neoplastic effects via apoptosis induction. Previous study showed delta12-PGJ2-induced apoptosis utilized caspase cascade through cytochrome c-dependent pathways in HeLa cells. In this study, the cellular mechanism of delta12-PGJ2- induced apoptosis in HeLa cells, specifically, the role of two mitochondrial factors; bcl-2 and apoptosis-inducing factor (AIF) was investigated. Bcl-2 attenuated delta12-PGJ2-induced caspase activation, loss of mitochondrial transmembrane potential (delta psi m), nuclear fragmentation, DNA laddering, and growth curve inhibition for approximately 24 h, but not for longer time. AIF was not released from mitochondria, even if the delta psi m was dissipated. One of the earliest events observed in delta12-PGJ2-induced apoptotic events was dissipation of delta psi m, the process known to be inhibited by bcl-2. Pre-treatment of z-VAD- fmk, the pan-caspase inhibitor, resulted in the attenuation of delta psi m depolarization in delta12-PGJ2- induced apoptosis. Up-regulation of Sox-4 protein by delta12-PGJ2 was observed in HeLa and bcl-2 overexpressing HeLa B4 cell lines. Bcl-2 overexpression did not attenuate the expression of Sox-4 and its expression coincided with other apoptotic events. These results suggest that delta12-PGJ2 induced Sox-4 expression may activate another upstream caspases excluding the caspase 9-caspase 3 cascade of mitochondrial pathway. These and previous findings together suggest that delta12-PGJ2-induced apoptosis in HeLa cells is caspase-dependent, AIF-independent events which may be affected by Sox-4 protein expression up-regulated by delta12-PGJ2.
Amino Acid Chloromethyl Ketones/pharmacology
;
Antineoplastic Agents/*pharmacology
;
Apoptosis/drug effects/*physiology
;
Caspases/physiology
;
Cytochromes c/physiology
;
Female
;
Flavoproteins/metabolism/*physiology
;
Hela Cells
;
High Mobility Group Proteins/*physiology
;
Humans
;
Membrane Proteins/metabolism/*physiology
;
Mitochondria/metabolism/physiology
;
Prostaglandin D2/*pharmacology
;
Protein Transport/physiology
;
Proto-Oncogene Proteins c-bcl-2/biosynthesis/*physiology
;
Research Support, Non-U.S. Gov't
;
Trans-Activation (Genetics)
;
Trans-Activators/*physiology
8.Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression in shikonin-induced HeLa cell apoptosis.
Zhen WU ; Li-jun WU ; Shinichi TASHIRO ; Satoshi ONODERA ; Takashi IKEJIMA
Chinese Medical Journal 2005;118(8):671-677
BACKGROUNDThe role of extracellular signal-regulated kinase 1/2 (ERK1/2) in shikonin-induced HeLa cells apoptosis remains vague. This study was to investigate the activation of caspase pathways and the role of ERK1/2 in human cervical cancer cells, HeLa, by shikonin.
METHODSThe inhibitory effect of shikonin on the growth of HeLa cells was measured by MTT assay. Fluorescent microscopic analysis of apoptotic cells stained with 4',6'-oliiamiclino-2-phenylindole C (DAPI) and Hoechst 33258 was carried out. Caspase-3 and -8 activities were detected using caspase-3 substrate and caspase-8 substrate as substrates, respectively. The protein levels of ERK, p53 and p-ERK were determined by Western blot analysis.
RESULTSShikonin inhibited cell growth in a time- and dose-dependent manner. Caspase-3 and caspase-8 were activated in the apoptotic process and caspase inhibitors effectively reversed shikonin-induced apoptosis. Phosphorylation of ERK resulted in up-regulation of p53 expression, which was blocked by mitogen-activated protein kinase (MEK), inhibitor PD 98059.
CONCLUSIONShikonin induces HeLa cell apoptosis through the ERK, p53 and caspase pathways.
Apoptosis ; drug effects ; Caspases ; physiology ; Cell Proliferation ; drug effects ; DNA Damage ; Flavonoids ; pharmacology ; HeLa Cells ; Humans ; Mitogen-Activated Protein Kinase 1 ; metabolism ; Mitogen-Activated Protein Kinase 3 ; metabolism ; Naphthoquinones ; pharmacology ; Phosphorylation ; Tumor Suppressor Protein p53 ; analysis ; Up-Regulation
9.ERp44 C160S/C212S mutants regulate IP3R1 channel activity.
Congyan PAN ; Ji ZHENG ; Yanyun WU ; Yingxiao CHEN ; Likun WANG ; Zhansong ZHOU ; Wenxuan YIN ; Guangju JI
Protein & Cell 2011;2(12):990-996
Previous studies have indicated that ERp44 inhibits inositol 1,4,5-trisphosphate (IP(3))-induced Ca(2+) release (IICR) via IP(3)R(1), but the mechanism remains largely unexplored. Using extracellular ATP to induce intracellular calcium transient as an IICR model, Ca(2+) image, pull down assay, and Western blotting experiments were carried out in the present study. We found that extracellular ATP induced calcium transient via IP(3)Rs (IICR) and the IICR were markedly decreased in ERp44 overexpressed Hela cells. The inhibitory effect of C160S/C212S but not C29S/T396A/ΔT(331-377) mutants of ERp44 on IICR were significantly decreased compared with ERp44. However, the binding capacity of ERp44 to L3V domain of IP(3)R(1) (1L3V) was enhanced by ERp44 C160S/C212S mutation. Taken together, these results suggest that the mutants of ERp44, C160/C212, can more tightly bind to IP(3)R(1) but exhibit a weak inhibition of IP(3)R(1) channel activity in Hela cells.
Adenosine Triphosphate
;
pharmacology
;
Amino Acid Substitution
;
Biological Transport
;
drug effects
;
physiology
;
Blotting, Western
;
Calcium
;
metabolism
;
Calcium Signaling
;
drug effects
;
physiology
;
HeLa Cells
;
Humans
;
Immunoprecipitation
;
Inositol 1,4,5-Trisphosphate
;
metabolism
;
Inositol 1,4,5-Trisphosphate Receptors
;
physiology
;
Membrane Potentials
;
drug effects
;
physiology
;
Membrane Proteins
;
genetics
;
metabolism
;
Microscopy, Confocal
;
Molecular Chaperones
;
genetics
;
metabolism
;
Mutation
;
Plasmids
;
Transfection
10.Influence of calcium ion on host cell invasion and intracellular replication by Toxoplasma gondii.
Hyun Ouk SONG ; Myoung Hee AHN ; Jae Sook RYU ; Duk Young MIN ; Kyoung Hwan JOO ; Young Ha LEE
The Korean Journal of Parasitology 2004;42(4):185-193
Toxoplasma gondii is an obligate intracellular protozoan parasite, which invades a wide range of hosts including humans. The exact mechanisms involved in its invasion are not fully understood. This study focused on the roles of Ca2+ in host cell invasion and in T. gondii replication. We examined the invasion and replication of T. gondii pretreated with several calcium modulators, the conoid extrusion of tachyzoites. Calmodulin localization in T. gondii were observed using the immunogold method, and Ca2+ levels in tachyzoites by confocal microscopy. In light microscopic observation, tachyzoites co-treated with A23187 and EGTA showed that host cell invasion and intracellular replication were decreased. The invasion of tachyzoites was slightly inhibited by the Ca2+ channel blockers, bepridil and verapamil, and by the calmodulin antagonist, calmidazolium. We observed that calcium saline containing A23187 induced the extrusion of tachyzoite conoid. By immunoelectron microscopy, gold particles bound to anti-calmodulin or anti-actin mAb, were found to be localized on the anterior portion of tachyzoites. Remarkably reduced intracellular Ca2+ was observed in tachyzoites treated with BAPTA/AM by confocal microscopy. These results suggest that host cell invasion and the intracellular replication of T. gondii tachyzoites are inhibited by the calcium ionophore, A23187, and by the extracellular calcium chelator, EGTA.
Animals
;
Calcium/*physiology
;
Calcium Channel Blockers/pharmacology
;
Calmodulin/antagonists & inhibitors
;
Chelating Agents/pharmacology
;
Hela Cells
;
Host-Parasite Relations
;
Humans
;
Ionophores/pharmacology
;
Research Support, Non-U.S. Gov't
;
Toxoplasma/drug effects/pathogenicity/*physiology